NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia
-
Published:2022-04-04
Issue:2
Volume:116
Page:199-214
-
ISSN:0925-5710
-
Container-title:International Journal of Hematology
-
language:en
-
Short-container-title:Int J Hematol
Author:
Marumo Atsushi, Wakita Satoshi, Morita Kaoru, Oh Iekuni, Kako Shinichi, Toya Takashi, Najima Yuho, Doki Noriko, Kanda Junya, Kuroda Junya, Mori Shinichiro, Satake Atsushi, Usuki Kensuke, Uoshima Nobuhiko, Kobayashi Yutaka, Kawata Eri, Nagao Yuhei, Shono Katsuhiro, Shibusawa Motoharu, Tadokoro Jiro, Hagihara Masao, Uchiyama Hitoji, Kubota Yasushi, Kimura Shinya, Motomura Sayuri, Hashimoto Akiko, Muto Hideharu, Sato Eriko, Ogata Masao, Mitsuhashi Kenjiro, Ando Jun, Date Kenta, Fujiwara Yusuke, Terada Kazuki, Yui Shunsuke, Arai Kunihito, Kitano Tomoaki, Miyata Miho, Ohashi Kazuteru, Kanda Yoshinobu, Yamaguchi HirokiORCID
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–47. 2. Miyawaki S, Emi N, Mitani K, Oyashiki K, Kitamura K, Morishita T, et al. Clinical course of the disease and the level of WT1 mRNA in 191 patients with acute myeloid leukemia (AML): joint research by 23 institutions in Japan. Rinsho Ketsueki. 2005;46(12):1279–87. 3. Miyawaki S, Hatsumi N, Tamaki T, Naoe T, Ozawa K, Kitamura K, et al. Prognostic potential of detection of WT1 mRNA level in peripheral blood in adult acute myeloid leukemia. Leuk Lymphoma. 2010;51(10):1855–61. 4. Gao MG, Ruan GR, Chang YJ, Liu YR, Qin YZ, Jiang Q, et al. The predictive value of minimal residual disease when facing the inconsistent results detected by real-time quantitative PCR and flow cytometry in NPM1-mutated acute myeloid leukemia. Ann Hematol. 2020;99(1):73–82. 5. Abdelhamid E, Preudhomme C, Helevaut N, Nibourel O, Gardin C, Rousselot P, et al. Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia. Leuk Res. 2012;36:316–23.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|